ASOP Global Names ASHP’s Schulte Wall to
Board of Directors
WASHINGTON, DC (March 5, 2020) – The Alliance for Safe Online Pharmacies (ASOP Global) has named Jillanne Schulte Wall, J.D. to its board of directors.
Ms. Wall currently serves as the Senior Director for Health & Regulatory Affairs for the American Society of Health-System Pharmacists (ASHP). In her role, she works closely with stakeholders in pharmacy, medicine, manufacturing and patient advocacy on issues of importance to hospital pharmacists with the ultimate goals of promoting.
“On behalf of our more than 50,000 pharmacist, student and technician members, I’m thrilled to be joining ASOP Global in promotion of improved medication use and patient health and safety efforts,” said Wall. “ASOP Global’s work is more important than ever given the ongoing discussions pertaining to drug supply chain security and the ongoing threat posed by illegal online drug sellers targeting U.S. consumers.”
“The ASOP Global Board is pleased to welcome Jillanne,” said Libby Baney, Senior Advisor to ASOP Global and partner at Faegre Drinker. “Her deep experience working on legislative and regulatory issues in healthcare and past experiences combatting threats from online drug sellers brings a valuable perspective to our efforts to engage pharmacists in helping to keep patients safe online.”
The ASOP Global Board of Directors comprises a diverse group of leaders with experience in healthcare, government, advocacy and industry. The board provides strategic direction for all of the nonprofit’s activities.
ABOUT ASOP GLOBAL
The Alliance for Safe Online Pharmacies (ASOP Global) is a 501(c)(4) nonprofit organization headquartered in Washington, D.C. with activities in U.S., Canada, Europe, Latin America and Asia. ASOP Global is dedicated to protecting consumers around the world, ensuring safe access to medications, and combating illegal online drug sellers. ASOP Global has an expansive membership including nonprofit public health organizations, international members, pharmacy members, as well as pharmaceutical manufacturers.